Cargando…

COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders

Detalles Bibliográficos
Autores principales:	Mongan, David, Cannon, Mary, Cotter, David R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256555/ https://www.ncbi.nlm.nih.gov/pubmed/32473945 http://dx.doi.org/10.1016/j.bbi.2020.05.067

Ejemplares similares

Prognostic models predicting transition to psychotic disorder using blood-based biomarkers: a systematic review and critical appraisal
por: Byrne, Jonah F., et al.
Publicado: (2023)

Plasma polyunsaturated fatty acids and mental disorders in adolescence and early adulthood: cross-sectional and longitudinal associations in a general population cohort
por: Mongan, David, et al.
Publicado: (2021)

Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence
por: Mongan, David, et al.
Publicado: (2021)

Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020)

The Burden of Hypercoagulability in COVID-19
por: Kim, Madeleine, et al.
Publicado: (2022)

Biomarkers of Hypercoagulability in COVID-19
por: Wada, Hideo
Publicado: (2023)

Psychotic experiences in the general population, a review; definition, risk factors, outcomes and interventions
por: Staines, Lorna, et al.
Publicado: (2022)

What Cuts in Federal COVID-19 Funding Could Mean for Rural Communities
por: Ruiz, Sienna, et al.
Publicado: (2022)

Incidence and persistence of psychotic experiences among young people
por: Staines, L, et al.
Publicado: (2023)

Incidence and Persistence of Psychotic Experiences in the General Population: Systematic Review and Meta-Analysis
por: Staines, Lorna, et al.
Publicado: (2023)

COVID-19 and Hypercoagulability: A Review
por: Kichloo, Asim, et al.
Publicado: (2020)

COVID-19 versus HIT hypercoagulability
por: Warkentin, Theodore E., et al.
Publicado: (2020)

Current Overview on Hypercoagulability in COVID-19
por: Singhania, Namrata, et al.
Publicado: (2020)

COVID-19 and hypercoagulability in the outpatient setting
por: Emert, Roger, et al.
Publicado: (2020)

EFFECT OF ANTICOAGULATION AND ANTIPLATELET AGENTS ON HYPERCOAGULABILITY STATES IN PATIENTS WITH COVID-19
por: UR, JEANNIE, et al.
Publicado: (2021)

F242. CHILDHOOD ADVERSITY AND PSYCHOTIC EXPERIENCES IN THE GENERAL POPULATION: WHAT IS THE PREDICTIVE ROLE OF RESILIENCE, COPING STYLE AND SOCIAL SUPPORT?
por: Mongan, David, et al.
Publicado: (2018)

Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients
por: van Veenendaal, Nadine, et al.
Publicado: (2020)

The association between transient childhood psychotic experiences and psychosocial outcomes in young adulthood: examining the role of mental disorder and attachment
por: Staines, L., et al.
Publicado: (2022)

S134. INCIDENCE, IMPACT AND TRAJECTORIES OF PSYCHOTIC EXPERIENCES FROM CHILDHOOD TO ADULTHOOD, AND PREDICTION OF PSYCHOTIC DISORDER
por: Zammit, Stanley, et al.
Publicado: (2020)

Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?
por: Föcking, Melanie, et al.
Publicado: (2016)

Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies
por: Mongan, David, et al.
Publicado: (2020)

Hypercoagulability in COVID-19: A review of the potential mechanisms underlying clotting disorders
por: Alam, Walid
Publicado: (2021)

The Role of Anticoagulation in COVID-19-Induced Hypercoagulability
por: Rico-Mesa, Juan Simon, et al.
Publicado: (2020)

Thrombotic and Hypercoagulability Complications of COVID-19: An Update
por: Shibeeb, Sapha, et al.
Publicado: (2021)

HYPERCOAGULABLE STATE: AN ENIGMA IN COVID-19 INFECTION
por: MILI, SAIMA, et al.
Publicado: (2021)

COVID-19 With Preexisting Hypercoagulability Digestive Disease
por: Jiang, Mingshan, et al.
Publicado: (2021)

COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

COVID-19-associated brief psychotic disorder
por: Smith, Colin M, et al.
Publicado: (2020)

Hypercoagulability following COVID-19 infection: at what stage is it safe to do a free flap?
por: Kanatas, A., et al.
Publicado: (2020)

Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort
por: Byrne, Jonah F., et al.
Publicado: (2022)

Papillophlebitis in a COVID-19 patient: Inflammation and hypercoagulable state
por: Insausti-García, Alfredo, et al.
Publicado: (2020)

Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients
por: Kitakata, Hiroki, et al.
Publicado: (2021)

Genetic Contributions to Reported Childhood Maltreatment: What It Means and How It Could Mean More
por: Miller, Alex P., et al.
Publicado: (2023)

Covid 19, lockdown and brief psychotic disorders
por: Cerejeira, J. Gonçalves, et al.
Publicado: (2021)

Long lasting hypercoagulability after subclinical COVID-19
por: Ferroli, Paolo, et al.
Publicado: (2020)

The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2020)

Acute pulmonary embolism in COVID-19 related hypercoagulability
por: Lorenzo, Cerruti, et al.
Publicado: (2020)

Clinical Features and Management of COVID-19–Associated Hypercoagulability
por: Massaro, Gianluca, et al.
Publicado: (2022)

Hypercoagulability of COVID-19 and Neurological Complications: A Review
por: Moore, Patrick, et al.
Publicado: (2022)

COVID-19 and ischemic stroke: Mechanisms of hypercoagulability (Review)
por: Zhang, Shuoqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_citcqa17qjs9cng81t8bjvddkh